NervGen Pharma Corp. Common stock (NGEN) is a publicly traded the market company. As of September 9, 2026, NGEN trades at $2.16 with a market cap of $250.53M and a P/E ratio of 0.00. NGEN moved -1.83% today. Year to date, NGEN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.58 to $6.30. Analyst consensus is strong buy with an average price target of $12.50. Rallies surfaces NGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NGEN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NGEN recently traded at $2.16. Market cap is $250.53M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $2.16 |
| Market Cap | $250.53M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.30 |
| 52-Week Low | $1.58 |
| Volume | 276.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover NGEN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.50.